RIGL
Rigel Pharmaceuticals Inc
Price:  
12.97 
USD
Volume:  
70,067.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

RIGL WACC - Weighted Average Cost of Capital

The WACC of Rigel Pharmaceuticals Inc (RIGL) is 7.0%.

The Cost of Equity of Rigel Pharmaceuticals Inc (RIGL) is 6.95%.
The Cost of Debt of Rigel Pharmaceuticals Inc (RIGL) is 9.40%.

Range Selected
Cost of equity 6.10% - 7.80% 6.95%
Tax rate 26.20% - 27.00% 26.60%
Cost of debt 7.00% - 11.80% 9.40%
WACC 5.9% - 8.0% 7.0%
WACC

RIGL WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 0.49 0.53
Additional risk adjustments 0.0% 0.5%
Cost of equity 6.10% 7.80%
Tax rate 26.20% 27.00%
Debt/Equity ratio 0.25 0.25
Cost of debt 7.00% 11.80%
After-tax WACC 5.9% 8.0%
Selected WACC 7.0%